Long term efficacy and safety of rivaroxaban plus cilostazol in the treatment of critical ischemia of the lower limbs in a frail, elderly patient with non valvular atrial fibrillation

BACKGROUND: Many patients with critical lower limb ischemia are not eligible for revascularization procedures. Still, given the emerging role of both platelet and coagulation activation in the formation of arterial thrombi, they may benefit from the novel anticoagulant and antiplatelet drugs. CASE P...

Descripción completa

Detalles Bibliográficos
Autores principales: Trani, Antonio, Benedetto, Pietro, Di Leo, Ferdinando, Baiano, Angela, Esposito, Andrea, Menna, Danilo, Allegretti, Arianna, Cappiello, Pierluigi Antonino, Dell’Edera, Domenico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398073/
https://www.ncbi.nlm.nih.gov/pubmed/32774874
http://dx.doi.org/10.1186/s40780-020-00173-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398073/
https://www.ncbi.nlm.nih.gov/pubmed/32774874
http://dx.doi.org/10.1186/s40780-020-00173-9

Ejemplares similares